FDA Pediatric Cancer Panel Suggests More International Research Collaboration

Drug Industry Daily
In the second day of a two-day meeting, an FDA pediatric cancer advisory panel suggested further international cooperation and emphasized the need for tailoring trials to their specific diseases, while recommending against the use of placebos in pediatric cancer drug trials.

To View This Article:


Subscribe To Drug Industry Daily